Extracorporeal removal of microvesicular particles
US9364601B2 · kind B2 · utility
8Cited by
15References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2012 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Apr 16, 2035 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01J20/3242
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
The invention described herein teaches methods of removing microvesicular particles, which include but are not limited to exosomes, from the systemic circulation of a subject in need thereof with the goal of reversing antigen-specific and antigen-nonspecific immune suppression. Said microvesicular particles could be generated by host cells that have been reprogrammed by neoplastic tissue, or the neoplastic tissue itself. Compositions of matter, medical devices, and novel utilities of existing medical devices are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.